scispace - formally typeset
K

Kenichi Kobayashi

Researcher at Kanazawa University

Publications -  329
Citations -  9744

Kenichi Kobayashi is an academic researcher from Kanazawa University. The author has contributed to research in topics: Hepatocellular carcinoma & Hepatitis. The author has an hindex of 51, co-authored 327 publications receiving 9523 citations. Previous affiliations of Kenichi Kobayashi include Tottori University & Tokyo Medical and Dental University.

Papers
More filters
Journal ArticleDOI

Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: A retrospective and nationwide survey in Japan

TL;DR: In this paper, the authors reviewed the standard results from each treatment based on an extensive survey and found that percutaneous ethanol injection (PEI), hepatic resection (HX), and transcatheter arterial embolization (TCAE) have all been used in the treatment of patients with small-sized hepatocellular carcinomas (HCCs).
Journal ArticleDOI

Benign and malignant nodules in cirrhotic livers: distinction based on blood supply.

TL;DR: Evaluation of the blood supply of the nodular lesions associated with liver cirrhosis is considered to be useful in the differential diagnosis and treatment of early-stage HCC.
Journal ArticleDOI

Detection of serum hepatitis B virus DNA in patients with chronic hepatitis using the polymerase chain reaction assay

TL;DR: Analysis by the PCR technique provides a greater than 10(4)-fold increase in sensitivity over the slot-blot hybridization assay, which represents an important breakthrough in sensitivity because it is now possible to detect as few as three HBV DNA genomes per sample of serum.
Journal ArticleDOI

RNA-dependent RNA polymerase activity of the soluble recombinant hepatitis C virus NS5B protein truncated at the C-terminal region.

TL;DR: The C-terminal region of NS5B, which is dispensable for the RdRP activity, dramatically affected the subcellular localization ofNS5B retaining it in perinuclear sites in transiently overexpressed mammalian cells and may provide some clues to dissecting the molecular mechanism of the HCV replication and also act as a basis for developing new anti-viral drugs.
Journal ArticleDOI

Hepatitis C virus (HCV) NS5A binds RNA-dependent RNA polymerase (RdRP) NS5B and modulates RNA-dependent RNA polymerase activity.

TL;DR: The idea that NS5A modulates HCV replication as a component of replication complex as well as the effect of His-NS5A on RdRP activity of the soluble recombinant NS5Bt in vitro is supported.